First Horizon Corporation’s Teva Pharmaceuticals TEVA Stock Holding History

First Horizon Corporation’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.8K	Buy	1,116 +175	+19%	+$5.83K	﹤0.01%	785
2026 Q1	$28.3K	Sell	941 -109	-10%	-$3.51K	﹤0.01%	795
2025 Q4	$32.8K	Hold	1,050	–	–	﹤0.01%	809
2025 Q3	$21.2K	Buy	+1,050	New	+$18.4K	﹤0.01%	845
2013 Q2	$47K	Buy	+1,188	New	+$46.3K	0.01%	345

Other funds holding TEVA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

BCM

Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

First Horizon Corporation's TEVA Position: Q2 2026 in Review

First Horizon Corporation increased its Teva Pharmaceuticals (TEVA) stake by 19% in Q2 2026, buying an estimated $5.83K and bringing the position to 1,116 shares worth $37.8K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

First Horizon Corporation first reported a position in TEVA in Q2 2013 and has held it in 5 quarters since. The position peaked at $47K in Q2 2013. 108 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

First Horizon Corporation held 1,116 shares of Teva Pharmaceuticals worth $37.8K as of Q2 2026.
First Horizon Corporation bought 175 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.83K.
Teva Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #785 holding.
First Horizon Corporation first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
First Horizon Corporation's Teva Pharmaceuticals position peaked at $47K in Q2 2013.
108 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.